Share-Based Plans (Details) (USD $) | 3 Months Ended | 9 Months Ended | |
Nov. 01, 2014 | Aug. 02, 2014 | 3-May-14 | Nov. 02, 2013 | Nov. 01, 2014 | Nov. 02, 2013 | Feb. 01, 2014 |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ' | ' | ' | ' | ' | ' | ' |
Allocated Share-based Compensation Expense | $3,000,000 | ' | ' | $3,700,000 | $8,000,000 | $11,500,000 | ' |
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions and Methodology [Abstract] | ' | ' | ' | ' | ' | ' | ' |
Weighted-average fair value of stock options granted | ' | ' | ' | $11.83 | ' | $12.08 | ' |
Risk-free interest rate | ' | ' | ' | 1.10% | ' | 0.70% | ' |
Expected life (years) | ' | ' | ' | '4 years 2 months 12 days | ' | '4 years 2 months 12 days | ' |
Expected volatility | ' | ' | ' | 39.90% | ' | 42.10% | ' |
Expected annual forfeiture rate | ' | ' | ' | 3.00% | ' | 3.00% | ' |
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward] | ' | ' | ' | ' | ' | ' | ' |
Outstanding stock options | 2,479,135 | 2,994,235 | 3,377,303 | ' | 3,377,303 | ' | ' |
Granted | ' | ' | ' | ' | 0 | ' | ' |
Exercised | -541,797 | -464,400 | -243,218 | ' | ' | ' | ' |
Forfeited | -72,500 | -50,700 | -139,850 | ' | ' | ' | ' |
Outstanding stock options | 1,864,838 | 2,479,135 | 2,994,235 | ' | 1,864,838 | ' | ' |
Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract] | ' | ' | ' | ' | ' | ' | ' |
Options, Vested and Expected to Vest, Outstanding, Number | 1,775,684 | ' | ' | ' | 1,775,684 | ' | ' |
Options, Exercisable, Number | 895,774 | ' | ' | ' | 895,774 | ' | ' |
Options, Outstanding, Weighted Average Exercise Price | $37.52 | $35 | $35.35 | ' | $37.52 | ' | $34.88 |
Options, Exercises in Period, Weighted Average Exercise Price | $25.75 | $36.73 | $26.90 | ' | ' | ' | ' |
Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price | $39.15 | $40.35 | $38.63 | ' | ' | ' | ' |
Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price | $37.48 | ' | ' | ' | $37.48 | ' | ' |
Options, Exercisable, Weighted Average Exercise Price | $36.89 | ' | ' | ' | $36.89 | ' | ' |
Options, Outstanding, Weighted Average Remaining Contractual Term | '4 years 3 months 18 days | '4 years 1 month | '4 years 2 months 18 days | ' | ' | ' | ' |
Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term | '4 years 2 months 12 days | ' | ' | ' | ' | ' | ' |
Options, Exercisable, Weighted Average Remaining Contractual Term | '3 years 6 months | ' | ' | ' | ' | ' | ' |
Options, Outstanding, Intrinsic Value | 15,162,000 | 20,850,000 | 16,314,000 | ' | 15,162,000 | ' | ' |
Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value | 14,515,000 | ' | ' | ' | 14,515,000 | ' | ' |
Options, Exercisable, Intrinsic Value | 7,845,000 | ' | ' | ' | 7,845,000 | ' | ' |
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Additional Disclosures [Abstract] | ' | ' | ' | ' | ' | ' | ' |
Total intrinsic value of stock options exercised | 11,050,000 | ' | ' | 625,000 | 16,980,000 | 2,414,000 | ' |
Employee Service Share-based Compensation, Nonvested Awards, Total Compensation Cost Not yet Recognized | 23,800,000 | ' | ' | ' | 23,800,000 | ' | ' |
Nonvested Awards, Total Compensation Cost Not yet Recognized, Period for Recognition | '2 years 0 months 2 days | ' | ' | ' | ' | ' | ' |
Stock Options [Member] | ' | ' | ' | ' | ' | ' | ' |
Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract] | ' | ' | ' | ' | ' | ' | ' |
Share-based Compensation Arrangement by Share-based Payment Award, Award Requisite Service Period | ' | ' | ' | ' | '4 years | ' | ' |
Share Based Compensation Arrangement By Share Based Payment Award, Award Expiration Period From Grant Date | ' | ' | ' | ' | '7 years | ' | ' |
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Additional Disclosures [Abstract] | ' | ' | ' | ' | ' | ' | ' |
Share-based Compensation Arrangement by Share-based Payment Award, Award Requisite Service Period | ' | ' | ' | ' | '4 years | ' | ' |
Share Based Compensation Arrangement By Share Based Payment Award, Award Expiration Period From Grant Date | ' | ' | ' | ' | '7 years | ' | ' |
Restricted Stock [Member] | ' | ' | ' | ' | ' | ' | ' |
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward] | ' | ' | ' | ' | ' | ' | ' |
Nonvested, beginning balance | 819,178 | 832,457 | 664,101 | ' | 664,101 | ' | ' |
Granted | 2,012 | 32,987 | 281,056 | ' | ' | ' | ' |
Vested | -31,000 | -23,776 | -13,500 | ' | ' | ' | ' |
Forfeited | -28,990 | -22,490 | -99,200 | ' | ' | ' | ' |
Nonvested, ending balance | 761,200 | 819,178 | 832,457 | ' | 761,200 | ' | ' |
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Additional Disclosures [Abstract] | ' | ' | ' | ' | ' | ' | ' |
Nonvested, Weighted Average Grant Date Fair Value | $38.16 | $38.04 | $37.77 | ' | $38.16 | ' | $38.34 |
Grants in Period, Weighted Average Grant Date Fair Value | $43.87 | $42.86 | $37.12 | ' | ' | ' | ' |
Vested in Period, Weighted Average Grant Date Fair Value | $34.75 | $33.65 | $34.75 | ' | ' | ' | ' |
Forfeited in Period, Weighted Average Grant Date Fair Value | $38.84 | $39.61 | $40.19 | ' | ' | ' | ' |
Restricted Stock [Member] | Nonemployee Board of Directors [Member] | ' | ' | ' | ' | ' | ' | ' |
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward] | ' | ' | ' | ' | ' | ' | ' |
Vested | ' | -23,776 | ' | ' | ' | ' | ' |
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Additional Disclosures [Abstract] | ' | ' | ' | ' | ' | ' | ' |
Deferred Compensation Arrangement, Fair Value of Shares Issued to Each Director | ' | 110,000 | ' | ' | ' | ' | ' |
Restricted Stock Awards (RSAs) [Member] | ' | ' | ' | ' | ' | ' | ' |
Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract] | ' | ' | ' | ' | ' | ' | ' |
Share-based Compensation Arrangement by Share-based Payment Award, Award Requisite Service Period | ' | ' | ' | ' | '5 years | ' | ' |
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Additional Disclosures [Abstract] | ' | ' | ' | ' | ' | ' | ' |
Share-based Compensation Arrangement by Share-based Payment Award, Award Requisite Service Period | ' | ' | ' | ' | '5 years | ' | ' |
Total fair value of equity instrument other than options vested | 1,325,000 | ' | ' | 0 | 2,736,000 | 1,434,000 | ' |
Restricted Stock Awards (RSAs) [Member] | Current [Member] | ' | ' | ' | ' | ' | ' | ' |
Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract] | ' | ' | ' | ' | ' | ' | ' |
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period | ' | ' | ' | ' | '5 years | ' | ' |
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Additional Disclosures [Abstract] | ' | ' | ' | ' | ' | ' | ' |
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period | ' | ' | ' | ' | '5 years | ' | ' |
Restricted Stock Units (RSUs) [Member] | ' | ' | ' | ' | ' | ' | ' |
Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract] | ' | ' | ' | ' | ' | ' | ' |
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period | ' | ' | ' | ' | '3 years | ' | ' |
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Additional Disclosures [Abstract] | ' | ' | ' | ' | ' | ' | ' |
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period | ' | ' | ' | ' | '3 years | ' | ' |
Performance Shares [Member] | ' | ' | ' | ' | ' | ' | ' |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ' | ' | ' | ' | ' | ' | ' |
Allocated Share-based Compensation Expense | ' | ' | ' | ' | 0 | ' | ' |
Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract] | ' | ' | ' | ' | ' | ' | ' |
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period | ' | ' | ' | ' | '3 years | ' | ' |
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Additional Disclosures [Abstract] | ' | ' | ' | ' | ' | ' | ' |
Share-based Compensation Arrangement by Share-based Payment Award, Shares Issued in Period | ' | ' | ' | ' | 434,124 | ' | ' |
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period | ' | ' | ' | ' | '3 years | ' | ' |
CEO Performance Share Units [Member] | ' | ' | ' | ' | ' | ' | ' |
Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract] | ' | ' | ' | ' | ' | ' | ' |
Share Based Compensation Arrangement By Share Based Payment Award, Award Expiration Period From Grant Date | ' | ' | ' | ' | '7 years | ' | ' |
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward] | ' | ' | ' | ' | ' | ' | ' |
Nonvested, beginning balance | ' | ' | 37,800 | ' | 37,800 | ' | ' |
Vested | -12,600 | -12,600 | ' | ' | ' | ' | ' |
Nonvested, ending balance | 12,600 | ' | ' | ' | 12,600 | ' | ' |
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Additional Disclosures [Abstract] | ' | ' | ' | ' | ' | ' | ' |
Nonvested, Weighted Average Grant Date Fair Value | ' | ' | ' | ' | ' | ' | $34.68 |
Share Based Compensation Arrangement By Share Based Payment Award, Award Expiration Period From Grant Date | ' | ' | ' | ' | '7 years | ' | ' |
Total fair value of equity instrument other than options vested | $585,000 | ' | ' | $0 | $1,143,000 | $0 | ' |